Robert Osborne

Robert Osborne has extensive experience in clinical development and operations, currently serving as Senior Director at Eli Lilly and Company since April 2013. Over the years, Robert has held various key roles, including Associate Director of Clinical Trial Management for Diabetes and Senior Scientist, where responsibilities included overseeing the development and validation of immunogenicity assays, managing vendor relationships, and providing scientific oversight during clinical trials. Robert's early career included roles in research and laboratory settings at institutions such as Ball State University and Indiana University, where foundational research in biogeochemistry and microbiology was conducted. Academically, Robert holds an MBA in Finance from Butler University, a Master's in Biology from Ball State University, and a Bachelor's in Microbiology from Indiana University Bloomington.